Related references
Note: Only part of the references are listed.Association of autonomic symptoms with presynaptic striatal dopamine depletion in drug-naive Parkinson's disease: An analysis of the PPMI data
Ryul Kim et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2019)
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies
Abhishekh H. Ashok et al.
PSYCHOPHARMACOLOGY (2019)
Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system
Antonio Martin-Bastida et al.
BRAIN (2019)
Effects of stimulant drug use on the dopaminergic system: A systematic review and meta-analysis of in vivo neuroimaging studies
Lisa Proebstl et al.
EUROPEAN PSYCHIATRY (2019)
Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
Ken Ikeda et al.
INTERNAL MEDICINE (2019)
Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters
Kevin G. Mulvihill
NEUROCHEMISTRY INTERNATIONAL (2019)
Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease
Han Soo Yoo et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
C-11-PE2I and F-18-Dopa PET for Assessing Progression Rate in Parkinson's: A Longitudinal Study
Weihua Li et al.
MOVEMENT DISORDERS (2018)
Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease
S. Prasad et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
I-123 DaTscan SPECT Brain Imaging in Parkinsonian Syndromes: Utility of the Putamen-to-Caudate Ratio
Manuela Matesan et al.
JOURNAL OF NEUROIMAGING (2018)
Can early dopamine transporter imaging serve as a predictor of Parkinson's disease progression and late motor complications?
Ruth Djaldetti et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
Tanya Simuni et al.
MOVEMENT DISORDERS (2018)
Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson's disease
Angelo Fabio Gigante et al.
NEUROLOGICAL SCIENCES (2018)
Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off
Su Jin Chung et al.
PARKINSONISM & RELATED DISORDERS (2018)
Neuropathology of Parkinson disease
Dennis W. Dickson
PARKINSONISM & RELATED DISORDERS (2018)
Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort
Ryul Kim et al.
PARKINSONISM & RELATED DISORDERS (2018)
Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
Jessika C. Bridi et al.
FRONTIERS IN NEUROSCIENCE (2018)
The Emerging Evidence of the Parkinson Pandemic
E. Ray Dorsey et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism
Nicola Pavese et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients
Carlo Rossi et al.
CLINICAL NEUROPHARMACOLOGY (2017)
Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome
Erik Mille et al.
JOURNAL OF NEUROIMAGING (2017)
Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
Alan J. Thomas et al.
NEUROLOGY (2017)
Compensatory mechanisms in Parkinson's disease: Circuits adaptations and role in disease modification
Javier Blesa et al.
EXPERIMENTAL NEUROLOGY (2017)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation
Jeanne C. Latourelle et al.
LANCET NEUROLOGY (2017)
The Role of High-Field Magnetic Resonance Imaging in Parkinsonian Disorders: Pushing the Boundaries Forward
Stephane Lehericy et al.
MOVEMENT DISORDERS (2017)
Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases
Yuanyuan Li et al.
NEUROLOGY (2017)
Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease
Laura Saari et al.
NEUROLOGY (2017)
Seven tesla MRI of the substantia nigra in patients with rapid eye movement sleep behavior disorder
Daniela Frosini et al.
PARKINSONISM & RELATED DISORDERS (2017)
In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies
Stefan T. Schwarz et al.
RADIOLOGY (2017)
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease
Jenny-Ann Phan et al.
SCIENTIFIC REPORTS (2017)
Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts
Usman Saeed et al.
TRANSLATIONAL NEURODEGENERATION (2017)
Dopamine Transporter Imaging Deficit Predicts Early Transition to Synucleinopathy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Alex Iranzo et al.
ANNALS OF NEUROLOGY (2017)
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies
Roberto Erro et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications
Matthias Loehle et al.
NEUROLOGY (2016)
Loss of Dorsolateral Nigral Hyperintensity on 3.0 Tesla Susceptibility-Weighted Imaging in Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Roberto De Marzi et al.
ANNALS OF NEUROLOGY (2016)
Cognition in Patients With a Clinical Diagnosis of Parkinson Disease and Scans Without Evidence of Dopaminergic Deficit (SWEDD): 2-Year Follow-Up
Kathryn A. Wyman-Chick et al.
COGNITIVE AND BEHAVIORAL NEUROLOGY (2016)
[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
J. J. van der Zande et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI
Daniela Frosini et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Early Synaptic Dysfunction in Parkinson's Disease: Insights From Animal Models
Tommaso Schirinzi et al.
MOVEMENT DISORDERS (2016)
Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I-FP-CIT SPECT
Yun Jung Bae et al.
MOVEMENT DISORDERS (2016)
Advances in markers of prodromal Parkinson disease
Ronald B. Postuma et al.
NATURE REVIEWS NEUROLOGY (2016)
Association of body mass index and the depletion of nigrostriatal dopamine in Parkinson's disease
Jae Jung Lee et al.
NEUROBIOLOGY OF AGING (2016)
Correlation between neuromelanin-sensitive MR imaging and 123I-FP-CIT SPECT in patients with parkinsonism
Keita Kuya et al.
NEURORADIOLOGY (2016)
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Ioannis U. Isaias et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease
D. Tomas et al.
PLOS ONE (2016)
Striatal dopamine neurotransmission: Regulation of release and uptake
David Sulzer et al.
BASAL GANGLIA (2016)
Lewy Bodies: A Spectator or Salient Killer?
Jeswinder Sian-Huelsmann et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
Nigral anatomy and striatal denervation in genetic Parkinsonism: A family report
Roberto Ceravolo et al.
MOVEMENT DISORDERS (2015)
Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease
Sofia Reimao et al.
MOVEMENT DISORDERS (2015)
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma et al.
MOVEMENT DISORDERS (2015)
Effects of aging and gender on striatal and extrastriatal [123I]FP-CIT binding in Parkinson's disease
Valtteri Kaasinen et al.
NEUROBIOLOGY OF AGING (2015)
Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake
Javier Castro-Hernandez et al.
NEUROBIOLOGY OF DISEASE (2015)
Parkinson disease and incidental Lewy body disease Just a question of time?
Diego Iacono et al.
NEUROLOGY (2015)
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients
Gabriella Santangelo et al.
PARKINSONISM & RELATED DISORDERS (2015)
Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration
Susanne Pirker et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients
S. Reimao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Central Pharmacokinetics of Levodopa: Lessons From Imaging Studies
A. Jon Stoessl
MOVEMENT DISORDERS (2015)
Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease
Anke A. Dijkstra et al.
PLOS ONE (2015)
Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson's disease
Chong S. Lee et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT
Anette Davidsson et al.
ANNALS OF NUCLEAR MEDICINE (2014)
Correlation of Striatal Dopamine Transporter Imaging With Post Mortem Substantia Nigra Cell Counts
Julia Kraemmer et al.
MOVEMENT DISORDERS (2014)
Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
Jin Yong Hong et al.
NEUROLOGY (2014)
Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging
Chigumi Ohtsuka et al.
PARKINSONISM & RELATED DISORDERS (2014)
Caudate dopaminergic denervation and visual hallucinations: Evidence from a 123I-FP-CIT SPECT study
Lorenzo Kiferle et al.
PARKINSONISM & RELATED DISORDERS (2014)
MR Imaging of the Substantia Nigra at 7 T Enables Diagnosis of Parkinson Disease
Mirco Cosottini et al.
RADIOLOGY (2014)
Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I-Metaiodobenzylguanidine Scintigraphy
F. Miyoshi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2013)
Validation of nigrostriatal positron emission tomography measures: Critical limits
Morvarid Karimi et al.
ANNALS OF NEUROLOGY (2013)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
I123-FP-CIT single-photon emission tomography in patients with long-standing mixed tremor
M. de Verdal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
No changes in striatal dopamine transporter in antidepressant-treated patients with major depression
Cheng-Kuan Wu et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease
Sonia Benitez-Rivero et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
Nin Bajaj et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update
Klaus Tatsch et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Visualization of nigrosome 1 and its loss in PD Pathoanatomical correlation and in vivo 7 T MRI
Anna I. Blazejewska et al.
NEUROLOGY (2013)
Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies
Shinichiro Kitao et al.
NEURORADIOLOGY (2013)
3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease
Kimihiro Ogisu et al.
NEURORADIOLOGY (2013)
Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
Chigumi Ohtsuka et al.
NEUROSCIENCE LETTERS (2013)
Evidence of delayed nigrostriatal dysfunction in corticobasal syndrome: A SPECT follow-up study
Roberto Ceravolo et al.
PARKINSONISM & RELATED DISORDERS (2013)
Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias
Sean J. Colloby et al.
BRAIN (2012)
Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease
Deniz Kahraman et al.
JOURNAL OF NEUROLOGY (2012)
Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson's Disease and Multiple System Atrophy
Laura D. Perju-Dumbrava et al.
MOVEMENT DISORDERS (2012)
Magnetic resonance imaging of the substantia nigra in Parkinson's disease
Stephane Lehericy et al.
MOVEMENT DISORDERS (2012)
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease
Bernard Ravina et al.
MOVEMENT DISORDERS (2012)
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients
Roberto Erro et al.
PARKINSONISM & RELATED DISORDERS (2012)
The relationship between cerebral vascular disease and parkinsonism: The VADO study
A. Antonini et al.
PARKINSONISM & RELATED DISORDERS (2012)
The aging striatal dopamine function
Olivier Darbin
PARKINSONISM & RELATED DISORDERS (2012)
[123I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism
Michele Tinazzi et al.
SCHIZOPHRENIA RESEARCH (2012)
Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease
Kenichi Kashihara et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporter
Melissa A. Stouffer et al.
JOURNAL OF NEUROCHEMISTRY (2011)
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases
Friederike Sixel-Doering et al.
JOURNAL OF NEUROLOGY (2011)
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
Roberto Cilia et al.
PLOS ONE (2011)
Clinical Progression in Parkinson Disease and the Neurobiology of Axons
Hsiao-Chun Cheng et al.
ANNALS OF NEUROLOGY (2010)
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Peter A. Kempster et al.
BRAIN (2010)
Differences in nigro-striatal impairment in clinical variants of early Parkinson's disease: evidence from a FP-CIT SPECT study
C. Rossi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
The role of DAT-SPECT in movement disorders
G. Kaegi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder a prospective study (vol 9, pg 1070, 2010)
A. Iranzo et al.
LANCET NEUROLOGY (2010)
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap
Paolo Calabresi et al.
LANCET NEUROLOGY (2010)
Mixed Tremors with Integrity of Nigrostriatal System: A Clinical and DAT-SPECT Follow-Up Study
Gennarina Arabia et al.
MOVEMENT DISORDERS (2010)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2010)
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
Thomas G. Beach et al.
ACTA NEUROPATHOLOGICA (2009)
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study
R. Nandhagopal et al.
BRAIN (2009)
Levodopa-Induced Dyskinesias in Parkinson Disease Are Independent of the Extent of Striatal Dopaminergic Denervation: A Pharmacological and SPECT Study
Gurutz Linazasoro et al.
CLINICAL NEUROPHARMACOLOGY (2009)
Combined Use of DAT-SPECT and Cardiac MIBG Scintigraphy in Mixed Tremors
Fabiana Novellino et al.
MOVEMENT DISORDERS (2009)
When Does Parkinson's Disease Begin?
Carles Gaig et al.
MOVEMENT DISORDERS (2009)
Aging effects on the dopamine transporter expression and compensatory mechanisms
Ignacio Cruz-Muros et al.
NEUROBIOLOGY OF AGING (2009)
PET demonstrates reduced dopamine transporter expression in PD with dyskinesias
A. R. Troiano et al.
NEUROLOGY (2009)
Mechanisms compensating for dopamine loss in early Parkinson disease
Jonathan Brotchie et al.
NEUROLOGY (2009)
Predictive Value of Nigrostriatal Dysfunction in Isolated Tremor: A Clinical and SPECT Study
Roberto Ceravolo et al.
MOVEMENT DISORDERS (2008)
Decreased dopamine transporter availability in male smokers - A dual isotope SPECT study
Yen Kuang Yang et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Dopamine transporter relation to dopamine turnover in Parkinson's disease:: A positron emission tomography study
Vesna Sossi et al.
ANNALS OF NEUROLOGY (2007)
Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies
John-Paul Taylor et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism
Elizabeth A. Bolan et al.
MOLECULAR PHARMACOLOGY (2007)
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
David Sulzer
TRENDS IN NEUROSCIENCES (2007)
Striatal FP-CIT uptake differs in the subtypes of early Parkinson's disease
J. Spiegel et al.
JOURNAL OF NEURAL TRANSMISSION (2007)
Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Ian McKeith et al.
LANCET NEUROLOGY (2007)
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging
Vicky L. Marshall et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease
Makoto Sasaki et al.
NEUROREPORT (2006)
The dopamine transporter proteome
GE Torres
JOURNAL OF NEUROCHEMISTRY (2006)
[123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease
M Lorberboym et al.
MOVEMENT DISORDERS (2006)
Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body-associated neuronal loss in the substantia Nigra
S Greffard et al.
ARCHIVES OF NEUROLOGY (2006)
123I-FP-ClT in progressive supranuclear palsy and in Parkinson's disease:: a SPECT serniquantitative study
L Filippi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation
JR Adams et al.
BRAIN (2005)
Presynaptic mechanisms of motor fluctuations in Parkinson's disease:: a probabilistic model
R de la Fuente-Fernández et al.
BRAIN (2004)
How does Parkinson's disease begin? The role of compensatory mechanisms
JA Obeso et al.
TRENDS IN NEUROSCIENCES (2004)
Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias
R de la Fuente-Fernández et al.
BRAIN (2004)
Parkinsonian signs and substantia nigra neuron density in decendents elders without PD
GW Ross et al.
ANNALS OF NEUROLOGY (2004)
Presymptomatic compensation in Parkinson's disease is not dopamine-mediated
E Bezard et al.
TRENDS IN NEUROSCIENCES (2003)
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
A Kugaya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
DAT imaging in drug-induced and psychogenic parkinsonism
E Tolosa et al.
MOVEMENT DISORDERS (2003)
Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism
GR Uhl
MOVEMENT DISORDERS (2003)
[123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease
W Gerschlager et al.
MOVEMENT DISORDERS (2002)
[123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression
K Marek et al.
NEUROLOGY (2001)
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease
E Bezard et al.
JOURNAL OF NEUROSCIENCE (2001)
Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD
M Guttman et al.
NEUROLOGY (2001)
Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations
R de la Fuente-Fernandez et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
Share Paper
